News and media coverage Press Releases Karma El Chalabi 11/16/23 Press Releases Karma El Chalabi 11/16/23 Kanna Health (now Kadence Bio) announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation Read More Press Releases Karma El Chalabi 1/26/23 Press Releases Karma El Chalabi 1/26/23 Kanna Health (now Kadence Bio) announces patent application publication Read More Press Releases Karma El Chalabi 6/30/22 Press Releases Karma El Chalabi 6/30/22 Kanna Health (now Kadence Bio) announces patent application publication for KH-001 as premature ejaculation treatment Read More
Press Releases Karma El Chalabi 11/16/23 Press Releases Karma El Chalabi 11/16/23 Kanna Health (now Kadence Bio) announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation Read More
Press Releases Karma El Chalabi 1/26/23 Press Releases Karma El Chalabi 1/26/23 Kanna Health (now Kadence Bio) announces patent application publication Read More
Press Releases Karma El Chalabi 6/30/22 Press Releases Karma El Chalabi 6/30/22 Kanna Health (now Kadence Bio) announces patent application publication for KH-001 as premature ejaculation treatment Read More
